Imaging Agent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A West Michigan man with pancreatic cancer was the first person in the world to test a new imaging agent, BAMF Health says.

Bawendi’s expertise in optics, fluorescent molecules and tissue imaging were instrumental in development of Lumicell Direct Visualization System, which is currently under FDA review

The new imaging agent Cytalux will now improve the accuracy of lung cancer tumour removal surgery. Imaging Agent Helps to Remove Lung Cancer Tumors: Study.

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY®(piflufolastat F 18) injection, an F 18-labeled prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging agent. With the recent announcement of the U.S. Food and Drug Administration (FDA) approval, SOFIE will provide a dependable and scalable manufacturing and distribution network to support Lantheus' PSMA-targeted product PYLARIFY. Under a commercial supply agreement with Lantheu...

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates First Patient Dosed in Validive ® Camsirubicin Run-in Clinical Trial Now Planned to Start in 2H 2021 Potential Utility Reported for MNPR-101 as Imaging Agent in Cancer Surgery WILMETTE, Ill., May 13, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced first quarter 2021 ...